Nonprofit · EIN 20-1048322
COPD FOUNDATION INC
Tax-exempt · CORAL GABLES, FL 33134
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| June 30, 2025 | 990 | $14,381,344 | $12,606,054 | $1,775,290 | $12,515,154 | $5,176,999 | $7,338,155 |
| June 30, 2024 | 990 | $10,974,474 | $10,855,388 | $119,086 | $10,152,011 | $4,715,573 | $5,436,438 |
| June 30, 2023 | 990 | $7,966,723 | $9,649,179 | -$1,682,456 | $8,911,710 | $3,687,084 | $5,224,626 |
Financial details: 990 for the year ended June 30, 2025
Revenue
- Contributions, gifts and grants
- $13,595,105
- of which government grants
- $17,644
- Program service revenue
- $189,245
- Investment income
- $544,334
- Net gain from sales of assets
- $273,770
- Net income from fundraising events
- $47,660
- Other revenue
- $52,660
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $939,333
- Other salaries and wages
- $2,972,638
- Salaries, compensation and benefits (total)
- $5,063,571
- Professional fundraising fees
- $0
- Legal fees
- $31,236
- Accounting fees
- $18,000
- Occupancy
- $6,844
- Travel
- $331,698
- Depreciation
- $6,075
- Program services (functional)
- $8,986,675
- Management and general (functional)
- $2,620,121
- Fundraising (functional)
- $999,258
Balance sheet and other
- Total assets, start of year
- $10,152,011
- Total assets, end of year
- $12,515,154
- Total liabilities, end of year
- $5,176,999
- Net assets, end of year
- $7,338,155
- Land, buildings and equipment
- $8,139
- Publicly traded securities
- $3,887,768
- Net assets without donor restrictions
- $2,710,580
- Net assets with donor restrictions
- $4,627,575
- Gross receipts
- $15,905,580
- Employees
- 46
- Volunteers
- 337
- Year formed
- 2004
- State of legal domicile
- FL
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended June 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JEAN WRIGHT MD MBA | CHIEF EXECUTIVE OFFICER Officer | 40 | $295,381 | $29,418 |
| VINCENT MALANGA | EVP, CHIEF INFORMATION OFFICER Officer | 40 | $220,776 | $19,380 |
| ELISHA MALANGA | CHIEF CORPORATE RELATIONS OFFICER Officer | 40 | $165,743 | $39,531 |
| KALEO CURTIS | CHIEF FINANCIAL OFFICER Officer | 40 | $168,644 | $31,524 |
| CRYSTAL ROTHHAAR | VP, MARKETING & COMMUNICATIONS Highest-paid employee | 40 | $150,024 | $18,273 |
| SASHA LAVIN | SR DIRECTOR OF FINANCE Highest-paid employee | 40 | $141,238 | $16,362 |
| DELIA PRIETO OLIVER | VP, BRONCHIECTASIS OPERATIONS Highest-paid employee | 40 | $123,543 | $17,328 |
| PETER AMARI | VP, INFORMATION TECHNOLOGY & DESIGN Highest-paid employee | 40 | $119,329 | $0 |
| JAMES D CRAPO MD | BOARD CHAIR Trustee or director | 10 | $0 | $0 |
| VALERIE CHANG ESQ | VICE CHAIR Trustee or director, Officer | 2 | $0 | $0 |
| RICHARD CASABURI PHD MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| STEW COGAN ESQ | DIRECTOR Trustee or director | 2 | $0 | $0 |
| PHYLISS DILORENZO | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MARK DRANSFIELD MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| LEONARD FROMER MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
11 more people on this return
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| MEILAN HAN MD | DIRECTOR Trustee or director | 2 | $0 |
| JIM HARRIS | DIRECTOR Trustee or director | 2 | $0 |
| JERRY KRISHNAN PHD | DIRECTOR Trustee or director | 2 | $0 |
| DAVID MANNINO PHD | DIRECTOR Trustee or director | 2 | $0 |
| WILLIAM PILKINGTON DPA MPA MA | DIRECTOR Trustee or director | 2 | $0 |
| CINDY PRAEGER EMP | DIRECTOR Trustee or director | 2 | $0 |
| MIKE ROGERS | DIRECTOR Trustee or director | 2 | $0 |
| JEAN ROMMES PHD | DIRECTOR Trustee or director | 2 | $0 |
| RISA STACK PHD | DIRECTOR Trustee or director | 2 | $0 |
| BYRON M THOMASHOW MD | DIRECTOR Trustee or director | 2 | $0 |
| JOHN TORRENCE | DIRECTOR Trustee or director | 2 | $0 |
990 for the year ended June 30, 2024: 28 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| JEAN WRIGHT MD MBA | CHIEF EXECUTIVE OFFICER Officer | 40 | $295,381 | $29,418 |
| VINCENT MALANGA | EVP, CHIEF INFORMATION OFF Officer | 40 | $220,776 | $19,380 |
| ELISHA MALANGA | CORPORATE RELATIONS OFFICE Officer | 40 | $165,743 | $39,531 |
| KALEO CURTIS | CHIEF FINANCIAL OFFICER Officer | 40 | $168,644 | $31,524 |
| CRYSTAL ROTHHAAR | VP, MARKETING & COMMUNICATIONS Highest-paid employee | 40 | $150,024 | $18,273 |
| SASHA LAVIN | SR DIRECTOR OF FINANCE Highest-paid employee | 40 | $141,238 | $16,362 |
| DELIA PRIETO OLIVER | VP, BRONCHIECTASIS OPERATIONS Highest-paid employee | 40 | $123,543 | $17,328 |
| PETER AMARI | VP, INFORMATION TECHNOLOGY Highest-paid employee | 40 | $119,329 | $0 |
| JAMES D CRAPO MD | BOARD CHAIR Trustee or director | 10 | $0 | $0 |
| WAYNE E WITHERS JR | VICE CHAIR/TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| BYRON M THOMASHOW MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| RICHARD CASABURI PHD MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| STEW COGAN ESQ | DIRECTOR Trustee or director | 2 | $0 | $0 |
| LEONARD FROMER MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| DONALD GRAY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MEILAN K HAN MD MS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MARK DRANSFIELD MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MIKE ROGERS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| HERBERT YARDLEY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| VALERIE CHANG ESQ | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MARK METERSKY MC FCCP | DIRECTOR Trustee or director | 2 | $0 | $0 |
| WILLIAM PILKINGTON DPA MPA MA | DIRECTOR Trustee or director | 2 | $0 | $0 |
| CINDY PRAEGER EMP | DIRECTOR Trustee or director | 2 | $0 | $0 |
| RISA STACK PHD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| PHYLISS DILORENZO | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JOHN TORRENCE | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JIM HARRIS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| JEAN ROMMES | DIRECTOR Trustee or director | 2 | $0 | $0 |
990 for the year ended June 30, 2023: 29 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| RUTH TAL-SINGER | FORMER PRESIDENT & CEO Former | 0 | $275,000 | $0 |
| VINCENT MALANGA | EVP, CHIEF INFORMATION OFFICER Officer | 40 | $230,745 | $17,634 |
| ELISHA MALANGA | CORPORATE RELATIONS OFFICER Officer | 40 | $169,424 | $35,697 |
| SASHA LAVIN | SR DIRECTOR OF FINANCE Key employee | 40 | $160,064 | $26,364 |
| KALEO CURTIS | CHIEF FINANCIAL OFFICER Officer | 40 | $147,462 | $32,217 |
| CHRISTINE NOVAK MICKA | SR DIRECTOR OF DEVELOPMENT Highest-paid employee | 40 | $136,088 | $28,347 |
| KRISTEN WILLARD | EVP, PUBLIC & PROFESSIONAL EDUCATION Highest-paid employee | 40 | $128,708 | $15,483 |
| CAROLYN JOHNSON | SR DIRECTOR OF COMMUNICATIONS & MARKETING Highest-paid employee | 40 | $131,884 | $0 |
| PETER AMARI | VP, INFORMATION TECHNOLOGY & DESIGN Highest-paid employee | 40 | $112,348 | $0 |
| JEAN WRIGHT MD MBA | CHIEF EXECUTIVE OFFICER Officer | 40 | $16,149 | $0 |
| JAMES D CRAPO MD | BOARD CHAIR Trustee or director, Officer | 10 | $0 | $0 |
| WAYNE E WITHERS JR | VICE-CHAIR, TREASURER Trustee or director, Officer | 2 | $0 | $0 |
| BYRON M THOMASHOW MD | CHIEF MEDICAL OFFICER Trustee or director, Officer | 2 | $0 | $0 |
| RICHARD CASABURI PHD MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| STEW COGAN ESQ | DIRECTOR Trustee or director | 2 | $0 | $0 |
| LEONARD FROMER MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| DONALD GRAY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MEILAN K HAN MD MS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MARK DRANSFIELD MD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MIKE ROGERS | DIRECTOR Trustee or director | 2 | $0 | $0 |
| HERB YARDLEY | DIRECTOR Trustee or director | 2 | $0 | $0 |
| VALERIE CHANG ESQ | DIRECTOR Trustee or director | 2 | $0 | $0 |
| MARK METERSKY MC FCCP | DIRECTOR Trustee or director | 2 | $0 | $0 |
| WILLIAM PILKINGTON DPA MPA MA | DIRECTOR Trustee or director | 2 | $0 | $0 |
| CINDY PRAEGER EMP | DIRECTOR Trustee or director | 2 | $0 | $0 |
| RISA STACK PHD | DIRECTOR Trustee or director | 2 | $0 | $0 |
| GERARD M TURINO MD | EMERITI MEMBER Trustee or director | 2 | $0 | $0 |
| ROBERT WISE MD | EMERITI MEMBER Trustee or director | 2 | $0 | $0 |
| GRACE ANNE DORNEY KOPPEL JD | EMERITI MEMBER Trustee or director | 2 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 3300 PONCE DE LEON BLVD, CORAL GABLES, FL 33134-7211
- Principal officer (990 for 2024)
- KALEO CURTIS, 3300 PONCE DE LEON BLVD, MIAMI, FL 33134
- Signed the 990
- KALEO CURTIS, CFO
- Phone
- (866) 731-2673
- Website
- WWW.COPDFOUNDATION.ORG
- Return prepared by
- ZOMMA GROUP LLP
Mission
THE COPD FOUNDATION WAS ESTABLISHED TO IMPROVE THE LIVES OF PEOPLE WITH COPD, BRONCHIECTASIS, AND NONTUBERCULOUS MYCOBACTERIAL (NTM) LUNG DISEASE THROUGH INITIATIVES THAT EXPAND SERVICES AND SPEED INNOVATIONS WHICH WILL MAKE TREATMENT MORE EFFECTIVE AND AFFORDABLE.WE DO THIS THROUGH SCIENTIFIC RESEARCH, EDUCATION, ADVOCACY, AND AWARENESS WITH THE GOAL OF DISEASE PREVENTION, SLOWED PROGRESSION, AND ULTIMATELY A CURE.
Program accomplishments
- RESEARCH & MEDICALTHE COPD FOUNDATION RESEARCH TEAM ENGAGES WITH MULTIPLE INDIVIDUALS AND ORGANIZATIONS TO SUPPORT RESEARCH STUDIES AND CLINICAL TRIALS. THESE STUDIES FOCUS ON A WIDE RANGE OF TOPICS THAT ALIGN WITH THE FOUNDATION MISSION. THESE INCLUDE PATIENT SYMPTOM TREATMENT, VIRTUAL COPD MANAGEMENT TOOLS, PATIENT FEEDBACK ON SCREENING TOOLS, AND DEVELOPMENT OF NEW THERAPIES AND MEDICAL DEVICES TO ADDRESS UNMET NEEDS. THE COPD FOUNDATION RESEARCH TEAM ALSO PARTICIPATED IN SEVERAL ACTIVITIES THAT ARE TARGETING PEOPLE WITH EARLY COPD WITH THE AIM TO DEVELOP APPROACHES THAT CAN BE USED TO SLOW DISEASE PROGRESSION THESE INCLUDE AN AMERICAN THORACIC SOCIETY EARLY DISEASE WORKING GROUP, CO-CHAIRED BY THE COPD FOUNDATION AND DISCUSSIONS RELATED TO THE DESIGN AND CONDUCT OF CLINICAL TRIALS IN PATIENTS WITH EARLY DISEASE.THE COPD FOUNDATION IS CONTINUING THE WORK OF THE PATIENT INSPIRED VALIDATION OF OUTCOME TOOLS (PIVOT) PROJECT. PIVOT WAS ESTABLISHED TO BE A DRIVING FORCE FOR INTEGRATING THE PATIENT AND THE PATIENT VOICE INTO CLINICAL OUTCOME MEASUREMENT VALIDATION AND SELECTION FOR USE IN CHRONIC LUNG DISEASE RESEARCH AND CLINICAL TRIALS. THE PIVOT PROJECT HAS PRODUCED TWO MANUSCRIPTS, ONE TO DESCRIBE THE OBJECTIVES OF PIVOT AND A SECOND REPORTING THE FIRST RESULTS OF ANALYSIS OF WHAT MATTERS MOST TO PATIENTS WITH COPD. OVER THE NEXT YEAR THE PIVOT TEAM WILL CONDUCT A SURVEY OF COPD PATIENTS TO BETTER UNDERSTAND THE HETEROGENEITY IN HOW COPD PATIENTS EXPERIENCE THEIR DISEASE IN THEIR DAILY LIVES AND WHAT IS MOST IMPORTANT TO THEM IN TERMS OF UNMET NEEDS. IN THE COMING YEAR, THE PIVOT TEAM WILL ALSO BEGIN SIMILAR WORK IN NON-CYSTIC FIBROSIS BRONCHIECTASIS.THE COPD FOUNDATION CONTINUES TO PRIORITIZE THE DEVELOPMENT OF ITS PATIENT POWERED RESEARCH NETWORK OR PPRN, A NETWORK IN WHICH PATIENTS ARE RECRUITED TO SHARE THEIR HEALTH INFORMATION AND DISEASE IMPACT. PATIENT PROVIDED HEALTH INFORMATION IS STORED IN A SECURE DATABASE AND IS USED TO SUPPORT PROJECTS WHERE PATIENT INPUT IS NEEDED. THE PPRN IS CURRENTLY BEING USED TO SUPPORT MULTIPLE ONGOING RESEARCH STUDIES AND CLINICAL TRIAL ACTIVITIES.Expenses $3,282,165
- BRONCHIECTASIS & NTM ASSOCIATIONTHE COPD FOUNDATION WAS APPROVED TO DO BUSINESS AS THE BRONCHIECTASIS AND NTM ASSOCIATION. WITH THIS APPROVAL, WE EMBARKED ON A REBRANDING EFFORT, ENSURING OUR COMMITMENT AND DEDICATION TO THIS PATIENT COMMUNITY.WE HAD ANOTHER SUCCESSFUL WORLD BRONCHIECTASIS DAY CAMPAIGN, REACHING OVER 2 MILLION PEOPLE. THE CAMPAIGN ALLOWED US TO BRING TOGETHER NEARLY 20 PATIENT ADVOCACY ORGANIZATIONS AND PROFESSIONAL SOCIETIES TO COLLABORATE IN SPREADING AWARENESS AND EDUCATION ON BRONCHIECTASIS.THE GOAL OF THE BRONCHIECTASIS AND NTM RESEARCH REGISTRY IS TO SUPPORT COLLABORATIVE RESEARCH AND ASSIST IN THE PLANNING OF MULTI-CENTER CLINICAL TRIALS FOR THE TREATMENT OF NON-CF BRONCHIECTASIS AND/OR NTM LUNG DISEASE. OVER THE COURSE OF THE YEAR, THE REGISTRY CONTINUED ENROLLING AND COLLECTING LONGITUDINAL DATA ON PARTICIPANTS, REACHING OVER 8,000 PARTICIPANTS AND UP TO 16 YEARS OF DATA ON SOME PARTICIPANTS. SEVERAL REGISTRY ABSTRACTS WERE PRESENTED AT INTERNATIONAL CONFERENCES AND MANUSCRIPTS WERE PUBLISHED AS A RESULT OF THE REGISTRY DATA COLLECTION. IN ADDITION, THE REGISTRY WAS UTILIZED TO FACILITATE RECRUITMENT INTO MAJOR CLINICAL TRIALS IN THIS SPACE.THE BRONCHIECTASIS AND NTM CARE CENTER NETWORK'S MISSION IS TO REDUCE THE TIME TO DIAGNOSIS AND SUPPORT HIGH QUALITY CARE FOR THIS PATIENT POPULATION. THE CARE CENTER NETWORK SUCCESSFULLY ONBOARDED 33 CENTERS AND CONTINUED PLANNING FOR THE NEXT REQUEST FOR APPLICATIONS.Expenses $3,658,163
- COMMUNITYTHE COPD360 COMMUNITY ENGAGEMENT COMMITTEE (COPD360CENCO), A DIVERSE PATIENTS AND CAREGIVERS COMMITTEE, CONTINUED TO MEET MONTHLY TO PROVIDE THE VOICE OF PATIENTS AND CAREGIVERS TO ALL THE COPD FOUNDATION'S EFFORTS, AND TO SUPPORT ITS INTERACTIONS WITH OTHER HEALTH CARE AND ADVOCACY ORGANIZATIONS. PATIENT AND CAREGIVER INVOLVEMENT IN GOVERNANCE AND EDUCATION IS THE MODEL ON WHICH THE COPD FOUNDATION WAS ESTABLISHED. WITH THAT CENTRAL GOAL, THE COPD FOUNDATION HAS BUILT TRUST WITHIN ITS MEMBERSHIP AND RELATED STAKEHOLDER GROUPS.MEMBERSHIP IN THE COPD FOUNDATION CAPTAINS PROGRAM GREW BY 13%. CAPTAINS SPREAD COPD AWARENESS IN THEIR STATE AND LOCAL AREAS, MENTOR FELLOW COPD COMMUNITY MEMBERS, AND PARTICIPATE IN GRASSROOTS ADVOCACY AND COMMUNITY BUILDING ACTIVITIES FOCUSED ON HEALTH POLICY ISSUES THAT ARE IMPORTANT TO THOSE WHO HAVE COPD AND OTHER CHRONIC LUNG DISEASES. THE COPD FOUNDATION CONTINUES TO SUPPORT PATIENT WELLBEING BY PROVIDING FREE MONTHLY SUPPORT GROUPS FOR PATIENTS AND CAREGIVERS. SUPPORT GROUPS ARE AVAILABLE FOR BOTH PATIENTS WITH COPD AND PATIENTS WITH BRONCHIECTASIS AND (NONTUBERCULOUS MYCOBACTERIAL) NTM LUNG DISEASE. HUNDREDS OF PATIENTS ATTEND THESE MEETINGS EACH MONTH TO DISCUSS THEIR EXPERIENCES AND LEARN ABOUT TOPICS SUCH AS STAYING HEALTHY DURING THE HOLIDAYS AND TALKING TO THEIR HEALTH CARE PROVIDERS ABOUT THEIR SPECIFIC ISSUES AND SYMPTOMS.Expenses $714,987
- PUBLIC & PROFESSIONAL EDUCATIONTHE COPD FOUNDATION CONTINUES TO ENSURE HIGH-QUALITY EVIDENCE-BASED EDUCATIONAL MATERIALS ARE AVAILABLE FOR INTERNAL AND EXTERNAL STAKEHOLDERS. THE COPD FOUNDATION PODCAST RELEASED 12 EPISODES IN 2025, PROVIDING INSIGHTS FROM KEY OPINION LEADERS (KOLS) ON TOPICS RELATED TO COPD CARE. TWO NEW PATIENT-FACING 101 DECKS, ONE FOCUSING ON INTRODUCING COPD, AND THE OTHER DISCUSSING GENETIC COPD. TWO NEW LANDING PAGES WERE ALSO DEVELOPED - ONE ON SEVERE COPD THAT PROVIDES GUIDANCE ON MANAGEMENT, AND THE OTHER ON GENETIC COPD, WHICH ENCOURAGES TESTING FOR THE GENETIC CONDITION. TO SUPPORT PEOPLE LIVING WITH COPD IN A GROUP SETTING, RESOURCES TO SUPPORT GROUPS IN PROVIDING EFFECTIVE PEER SUPPORT AND EDUCATION WERE CREATED AND PROVIDED TO SEVERAL COMMUNITIES IN RURAL AREAS ACROSS THE COUNTRY. TO HELP IMPROVE THE DIAGNOSIS OF COPD IN RURAL COMMUNITIES, COPD SCREENING AND COPD EDUCATION WERE CONDUCTED AT NUMEROUS EVENTS IN FOUR STATES IN THE APPALACHIAN REGION. A MEDIA AND DIRECT MAIL CAMPAIGN PROMOTED COPD AWARENESS, AND THE USE OF PULMONARY REHABILITATION IN THESE AREAS, AND THREE PULMONARY REHABILITATION PROGRAMS IN THESE REGIONS WERE PROVIDED WITH FREE EDUCATIONAL MATERIALS.THE COPD FOUNDATION ALSO DEMONSTRATES A COMMITMENT TO PROVIDING HIGH-QUALITY EDUCATION FOR HEALTH CARE PROVIDERS WHO CARE FOR PEOPLE WITH CHRONIC LUNG DISEASE. SEVERAL CONTINUING MEDICAL EDUCATION PROGRAMS OR ACCREDITED PROGRAMS WERE PROVIDED FOR PROFESSIONAL DEVELOPMENT. THE LUNG HEALTH COLLABORATIVE WAS DEVELOPED AS A COMMUNITY OF PROVIDERS COMMITTED TO PROVIDING EFFECTIVE CARE FOR PEOPLE WITH CHRONIC LUNG DISEASE. THIS GROUP HAS AN ONLINE FORUM FOR COLLABORATION AND A DEDICATED NEWSLETTER. THE INAUGURAL LUNG HEALTH COLLABORATIVE VIRTUAL ASSEMBLY PROVIDED A FULL DAY OF EDUCATIONAL SESSIONS FOR HEALTH PROFESSIONALS. THESE SESSIONS WERE HELD BY KOLS AND DISCUSSED NOVEL COMPONENTS OF COPD CARE.Expenses $666,485
- ADVOCACY & PUBLIC POLICYTHE COPD FOUNDATION COMMUNITY WORKS WITH LOCAL, STATE, AND FEDERAL POLICY MAKERS TO INCREASE RESEARCH FUNDING, IMPROVE CARE DELIVERY, PROTECT ACCESS TO TREATMENTS, AND CREATE POLICY THAT IMPROVES THE LIVES OF THOSE WITH COPD, BRONCHIECTASIS AND NONTUBERCULOUS MYCOBACTERIAL (NTM) LUNG DISEASE. THE COPD FOUNDATION CENTERED ITS FY25 POLICY EFFORTS ON THE FOLLOWING PRIORITIES:1. INCREASING RESEARCH FUNDING2. ADVANCING PATIENT-CENTERED TREATMENT APPROVALS3. IMPROVING ACCESS TO OXYGEN THERAPY4. EXPANDING PULMONARY REHABILITATION5. REDUCING TOBACCO AND NICOTINE USEPROGRESS HAS BEEN MADE ON ALL POLICY PRIORITIES AS A DIRECT RESULT OF COPD FOUNDATION ADVOCACY EFFORTS. THIS INCLUDES THE PROGRESSION OF PULMONARY REHABILITATION AND SUPPLEMENTAL OXYGEN LEGISLATION THROUGH CONGRESS AND THE SUBMISSION OF OVER 100 BUDGET REQUESTS TO LEGISLATIVE OFFICES FOR THE FY26 APPROPRIATIONS CYCLE. OVER 75 ADVOCATES JOINED THE COPD FOUNDATION IN WASHINGTON, D.C. TO ADVOCATE FOR CRITICAL LUNG HEALTH POLICIES DURING THE IMPACT LUNG HEALTH 2025 LEGISLATIVE ADVOCACY CAMPAIGN, REPRESENTING 52 SENATE DISTRICTS, 53 HOUSE DISTRICTS, AND 26 STATES.Expenses $664,875
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in June, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | June 30, 2026 | November 16, 2026 | Not due yet |
| 2024 | June 30, 2025 | November 17, 2025 | 990 on file |
| 2023 | June 30, 2024 | November 15, 2024 | 990 on file |
IRS record
- EIN
- 20-1048322
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2005
- Accounting year ends
- June
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Voluntary health associations and medical disciplines (G43)
- Assets (IRS master file)
- $12,515,154
- Income (IRS master file)
- $15,905,580
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | June 2025 | $14,381,344 | $12,606,054 | $12,515,154 | XML |
| 990 | June 2024 | $10,974,474 | $10,855,388 | $10,152,011 | IRS |
| 990 | June 2023 | $7,966,723 | $9,649,179 | $8,911,710 | XML |
| 990 | June 2022 | $7,994,347 | $8,513,991 | $9,619,205 | IRS |
| 990 | June 2021 | – | – | – | IRS |
| 990 | June 2020 | – | – | – | IRS |
| 990 | June 2019 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 20-1048322).
Questions about COPD FOUNDATION INC
- What is the EIN of COPD FOUNDATION INC?
- The employer identification number (EIN) of COPD FOUNDATION INC is 20-1048322.
- Is COPD FOUNDATION INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2005.
- Are donations to COPD FOUNDATION INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does COPD FOUNDATION INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of COPD FOUNDATION INC due?
- The return for tax year 2025 (the year ending June 30, 2026) is due November 16, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did COPD FOUNDATION INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended June 2025.
- Who is the principal officer of COPD FOUNDATION INC?
- The 990 for the year ended June 30, 2025 names KALEO CURTIS.
- Who are the officers and directors of COPD FOUNDATION INC?
- The 990 for the year ended June 30, 2025 lists 26 people; 8 received compensation from the organization, the highest $295,381 (JEAN WRIGHT MD MBA, CHIEF EXECUTIVE OFFICER).
- How much revenue does COPD FOUNDATION INC have?
- On its 990 for the year ended June 30, 2025 it reported revenue of $14,381,344, expenses of $12,606,054 and total assets of $12,515,154 at year end.
Other nonprofits in CORAL GABLES
- MIAMI CANCER INSTITUTE AT BAPTIST HEALTH INC EIN 47-3090066 · last filed 990 for 2025
- LIVE LIKE BELLA INC EIN 46-2965698 · last filed 990 for 2024
- FIDEC INC EIN 13-4186589 · last filed 990 for 2025
- CAPS INTERNATIONAL INC EIN 45-3934746 · last filed 990 for 2025
- 305 PINK PACK INC EIN 84-3414585 · last filed 990 for 2025
- BARDO FOUNDATION INC EIN 30-1281323 · last filed 990-EZ for 2024
- BABAS BUNCH FOUNDATION INC EIN 46-3201421 · last filed 990-EZ for 2025
- SPECTRUM FAMILY EIN 83-2513202 · last filed 990-N for 2025
All nonprofits in CORAL GABLES · Florida · Voluntary health associations and medical disciplines